Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kyungwan Hong

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
BMJ Evidence-Based Medicine|February 26, 2021
COVID-19 information in news media: room for greater transparencyAnisa Rowhani-Farid, Kyungwan Hong
Journal of Managed Care & Specialty Pharmacy|May 7, 2015
HEDIS Antidepressant Measures Biased by 2013 RevisionKyungwan Hong, Greg Low, Jeffrey B Weilburg
Clinical Trials (London, England)|April 13, 2023
Definition and rationale for placebo composition: Cross-sectional analysis of randomized trials and protocols published in high-impact medical journalsKyungwan Hong, Anisa Rowhani-Farid, Peter Doshi
Journal of General Internal Medicine|March 17, 2022
Assessing Muscle-Related Adverse Events in Randomized Trials of StatinsPeter Doshi, Kyungwan Hong, Sarah Tanveer, et al.
Research in Social & Administrative Pharmacy : RSAP|December 18, 2018
Medication errors in community pharmacies: The need for commitment, transparency, and researchKyungwan Hong, Yoon Duk Hong, Catherine E Cooke
Journal of General Internal Medicine|October 30, 2019
Reporting of Drug Benefit in FDA-Approved Prescription Drug LabelingBansri Desai, Kyungwan Hong, John H Powers, et al.
Journal of General Internal Medicine|February 9, 2022
Evaluation of Publicly Available Information on Sex-Related Differences in the Efficacy and Safety of Newly Approved MedicationsKyungwan Hong, Sarah Tanveer, Hazem E Hassan, et al.
Clinical Trials (London, England)|August 28, 2019
Availability of study protocols for randomized trials published in high-impact medical journals: A cross-sectional analysisO'Mareen Spence, Kyungwan Hong, Richie Onwuchekwa Uba, et al.
Lancet (London, England)|March 21, 2021
Control vaccine formulationPeter Doshi, Kyungwan Hong, Tom Jefferson, et al.
Clinical Pharmacology and Therapeutics|April 3, 2021
Evaluation of Switch-to-Brand Rates as a Potential Signal for Therapeutic Equivalency of Generic Antidepressants: A Real-World Retrospective Cohort StudyShamir Kalaria, O'Mareen Spence, Kyungwan Hong, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
BMJ Evidence-Based Medicine|February 26, 2021
COVID-19 information in news media: room for greater transparencyAnisa Rowhani-Farid, Kyungwan Hong
Journal of Managed Care & Specialty Pharmacy|May 7, 2015
HEDIS Antidepressant Measures Biased by 2013 RevisionKyungwan Hong, Greg Low, Jeffrey B Weilburg
Clinical Trials (London, England)|April 13, 2023
Definition and rationale for placebo composition: Cross-sectional analysis of randomized trials and protocols published in high-impact medical journalsKyungwan Hong, Anisa Rowhani-Farid, Peter Doshi
Journal of General Internal Medicine|March 17, 2022
Assessing Muscle-Related Adverse Events in Randomized Trials of StatinsPeter Doshi, Kyungwan Hong, Sarah Tanveer, et al.
Research in Social & Administrative Pharmacy : RSAP|December 18, 2018
Medication errors in community pharmacies: The need for commitment, transparency, and researchKyungwan Hong, Yoon Duk Hong, Catherine E Cooke
Journal of General Internal Medicine|October 30, 2019
Reporting of Drug Benefit in FDA-Approved Prescription Drug LabelingBansri Desai, Kyungwan Hong, John H Powers, et al.
Journal of General Internal Medicine|February 9, 2022
Evaluation of Publicly Available Information on Sex-Related Differences in the Efficacy and Safety of Newly Approved MedicationsKyungwan Hong, Sarah Tanveer, Hazem E Hassan, et al.
Clinical Trials (London, England)|August 28, 2019
Availability of study protocols for randomized trials published in high-impact medical journals: A cross-sectional analysisO'Mareen Spence, Kyungwan Hong, Richie Onwuchekwa Uba, et al.
Lancet (London, England)|March 21, 2021
Control vaccine formulationPeter Doshi, Kyungwan Hong, Tom Jefferson, et al.
Clinical Pharmacology and Therapeutics|April 3, 2021
Evaluation of Switch-to-Brand Rates as a Potential Signal for Therapeutic Equivalency of Generic Antidepressants: A Real-World Retrospective Cohort StudyShamir Kalaria, O'Mareen Spence, Kyungwan Hong, et al.
Pageof 2